We watch official US product-safety, customs and trade sources and publish a versioned change ledger for cross-border sellers. Every entry keeps its source URL, first-seen and last-seen dates.
Six federal agencies. Thirty-day window. Each document is quoted as published, filed to an append-only monthly ledger, and never silently rewritten. No interpretation, no ranking, no legal advice.
Pricing is a proposal. Nothing is charged on this page and no checkout exists.
One entry per official document that can change an import, a label, an advertising claim or a landed cost. Procedural notices — meetings, accreditations, information collections, corrections, eCTD/biologics — are filtered out.
CPSC rules and safety standards for consumer products, including batteries and children's products, with the citation and date as published.
CBP entry and import procedure, USTR Section 301/232 actions, and ITA antidumping and countervailing findings that set cash-deposit rates.
FDA labelling and import requirements, and FTC advertising and endorsement rules that reach listings and influencer posts.
Four most recently published documents. Every entry links to the Federal Register and carries its first-seen and last-seen dates.
No abstract was published.
The Food and Drug Administration (FDA or we) is announcing the availability of a final guidance for industry entitled "New Dietary Ingredient (NDI) Notifications and Related Issues; Identity and Safety Information About the NDI: Guidance for Industry." The gui…
The U.S. Department of Commerce (Commerce) preliminarily determines that Fuding Industries Company Limited (Fuding) did not make sales of subject merchandise at less than normal value during the period of review (POR), November 29, 2023, through May 31, 2025. …
The U.S. Department of Commerce (Commerce) determines that producers and/or exporters subject to this administrative review sold subject merchandise at less than normal value during the period of review (POR), January 1, 2024, through December 31, 2024.
Three ways to read the same ledger. Prices are a proposal in USD; no plan is on sale and no payment is collected here.
Free · one email a week
Proposed · same-day alerts
Static read-only slices · no key
These are proposed tiers for validation, not a live offer. No card fields, no checkout, no subscription is created. The free tier describes the same data as the paid tiers, one week later.
Facts stay as published. The only transformation is trimming an abstract to the text the agency published.
Last ingest run. If a source fails, the run is recorded and the build continues with the others.
| Source | Label | Scanned | Matched | Status |
|---|---|---|---|---|
| CPSC (Consumer Product Safety Commission) | Product safety | 8 | 3 | ok |
| CBP (U.S. Customs and Border Protection) | Customs & imports | 17 | 3 | ok |
| FTC (Federal Trade Commission) | Advertising & claims | 7 | 0 | ok |
| FDA (Food and Drug Administration) | Food, drugs & labelling | 64 | 10 | ok |
| USTR (Office of the U.S. Trade Representative) | Tariffs & trade policy | 5 | 3 | ok |
| ITA (International Trade Administration) | Trade remedies | 116 | 95 | ok |
The Federal Register API, filtered to six agencies: CPSC, CBP, FTC, FDA, USTR and ITA. Titles, abstracts, citations and dates are used exactly as published. Each entry links to its source document.
No. The ledger records that a document was published and what it says. It does not tell you whether or how it applies to your product. Check the source and take qualified advice before acting.
Each monthly file is append-only. A re-seen item gets an updated last-seen date; if its published text changes, a new record is appended and the old one stays in history. Nothing is deleted or silently edited.
Yes. The static API under /api/ is free and needs no key: full current view, latest 50, last-7-days and per-agency slices. The sample alert is generated from the same entries. The proposed paid tiers add filters and alert delivery, not access to the current view.
No. OpenYuri is an independent practice. It is not a registered company, and this page makes no claims about clients, revenue or endorsements.